ArticleTherapeutic advances in chronic disease2021

A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus.

Shuo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.